Deutsche Bank Ag\ Point Biopharma Global Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$6.67 - $9.71 $38,932 - $56,677	5,837 Added 14.54%	45,988 $306,000
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $150,721 - $238,605	-21,971 Reduced 35.37%	40,151 $363,000
Q1 2023 May 15, 2023	BUY	$6.78 - $8.1 $124,101 - $148,262	18,304 Added 41.77%	62,122 $451,000
Q4 2022 Feb 13, 2023	BUY	$5.72 - $9.78 $67,919 - $116,127	11,874 Added 37.17%	43,818 $319,000
Q3 2022 Nov 14, 2022	SELL	$7.24 - $10.31 $72,733 - $103,574	-10,046 Reduced 23.92%	31,944 $246,000
Q2 2022 Aug 11, 2022	BUY	$5.6 - $9.5 $235,143 - $398,905	41,990 New	41,990 $286,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.